RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Clinical trial NCT00060515 · TERMINATED
Trial details
- NCT number
- NCT00060515
- Sponsor
- Repligen Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.